Literature DB >> 24131926

Coordinated regulation of p31(Comet) and Mad2 expression is required for cellular proliferation.

Dipali A Date1, Amy C Burrows1, Monica Venere2, Mark W Jackson3, Matthew K Summers4.   

Abstract

p31(Comet) is a well-known interacting partner of the spindle assembly checkpoint (SAC) effector molecule Mad2. At the molecular level it is well established that p31(Comet) promotes efficient mitotic exit, specifically the metaphase-anaphase transition, by antagonizing Mad2 function. However, there is little knowledge of how p31(Comet) is regulated or the physiological importance of controlling p31(Comet). Here, we show that the Rb-E2F pathway regulates p31(Comet) expression. In multiple tumor types (including breast and lung) p31(Comet) expression is increased along with Mad2. Expression of this antagonist-target pair is coordinated in cells and correlated in cancer. Moreover, a narrow range of p31(Comet):Mad2 ratios is compatible with cellular viability. Our data suggest that coordinate regulation is important for the outgrowth of oncogenic cell populations. Our findings suggest that altered p31(Comet):Mad2 expression ratios may provide new insight into altered SAC function and the generation of chromosomal instability in tumors.

Entities:  

Keywords:  E2F; Mad2; Rb; cancer; cell cycle; p31Comet; spindle assembly checkpoint

Mesh:

Substances:

Year:  2013        PMID: 24131926      PMCID: PMC3905074          DOI: 10.4161/cc.26811

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  53 in total

1.  Frequent mutations of human Mad2, but not Bub1, in gastric cancers cause defective mitotic spindle checkpoint.

Authors:  Han-Soo Kim; Kyung Hwa Park; Sun A Kim; Jing Wen; Seung Woo Park; Byungkyu Park; Chang-Woo Gham; Woo Jin Hyung; Sung Hoon Noh; Ho Kun Kim; Si Young Song
Journal:  Mutat Res       Date:  2005-10-15       Impact factor: 2.433

2.  Inactivation of p53 function in cultured human mammary epithelial cells turns the telomere-length dependent senescence barrier from agonescence into crisis.

Authors:  James C Garbe; Charles R Holst; Ekaterina Bassett; Thea Tlsty; Martha R Stampfer
Journal:  Cell Cycle       Date:  2007-05-30       Impact factor: 4.534

3.  Monoallelic BUB1B mutations and defective mitotic-spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome.

Authors:  Shinya Matsuura; Yoshiyuki Matsumoto; Ken-ichi Morishima; Hideki Izumi; Hiroshi Matsumoto; Emi Ito; Keisuke Tsutsui; Junya Kobayashi; Hiroshi Tauchi; Yoshinori Kajiwara; Seiji Hama; Kaoru Kurisu; Hidetoshi Tahara; Mitsuo Oshimura; Kenshi Komatsu; Tatsuro Ikeuchi; Tadashi Kajii
Journal:  Am J Med Genet A       Date:  2006-02-15       Impact factor: 2.802

4.  Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells.

Authors:  L I Huschtscha; J R Noble; A A Neumann; E L Moy; P Barry; J R Melki; S J Clark; R R Reddel
Journal:  Cancer Res       Date:  1998-08-15       Impact factor: 12.701

5.  Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit.

Authors:  Ulrich K Binné; Marie K Classon; Frederick A Dick; Wenyi Wei; Michael Rape; William G Kaelin; Anders M Näär; Nicholas J Dyson
Journal:  Nat Cell Biol       Date:  2006-12-24       Impact factor: 28.824

6.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice.

Authors:  Rocío Sotillo; Eva Hernando; Elena Díaz-Rodríguez; Julie Teruya-Feldstein; Carlos Cordón-Cardo; Scott W Lowe; Robert Benezra
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

7.  The consensus coding sequences of human breast and colorectal cancers.

Authors:  Tobias Sjöblom; Siân Jones; Laura D Wood; D Williams Parsons; Jimmy Lin; Thomas D Barber; Diana Mandelker; Rebecca J Leary; Janine Ptak; Natalie Silliman; Steve Szabo; Phillip Buckhaults; Christopher Farrell; Paul Meeh; Sanford D Markowitz; Joseph Willis; Dawn Dawson; James K V Willson; Adi F Gazdar; James Hartigan; Leo Wu; Changsheng Liu; Giovanni Parmigiani; Ben Ho Park; Kurtis E Bachman; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu
Journal:  Science       Date:  2006-09-07       Impact factor: 47.728

8.  Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation.

Authors:  A J Brenner; M R Stampfer; C M Aldaz
Journal:  Oncogene       Date:  1998-07-16       Impact factor: 9.867

9.  Patterns of somatic mutation in human cancer genomes.

Authors:  Christopher Greenman; Philip Stephens; Raffaella Smith; Gillian L Dalgliesh; Christopher Hunter; Graham Bignell; Helen Davies; Jon Teague; Adam Butler; Claire Stevens; Sarah Edkins; Sarah O'Meara; Imre Vastrik; Esther E Schmidt; Tim Avis; Syd Barthorpe; Gurpreet Bhamra; Gemma Buck; Bhudipa Choudhury; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kris Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jon Hinton; Andy Jenkinson; David Jones; Andy Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; Dave Richardson; Rebecca Shepherd; Alexandra Small; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; Daniel P Cahill; David N Louis; Peter Goldstraw; Andrew G Nicholson; Francis Brasseur; Leendert Looijenga; Barbara L Weber; Yoke-Eng Chiew; Anna DeFazio; Mel F Greaves; Anthony R Green; Peter Campbell; Ewan Birney; Douglas F Easton; Georgia Chenevix-Trench; Min-Han Tan; Sok Kean Khoo; Bin Tean Teh; Siu Tsan Yuen; Suet Yi Leung; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

10.  Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized.

Authors:  Yizheng Li; Jing Pan; Jian-Liang Li; Jee Hyung Lee; Chris Tunkey; Katie Saraf; James C Garbe; Maryann Z Whitley; Scott A Jelinsky; Martha R Stampfer; Steven A Haney
Journal:  Mol Cancer       Date:  2007-01-18       Impact factor: 27.401

View more
  5 in total

1.  Mad2 Overexpression Uncovers a Critical Role for TRIP13 in Mitotic Exit.

Authors:  Daniel Henry Marks; Rozario Thomas; Yvette Chin; Riddhi Shah; Christine Khoo; Robert Benezra
Journal:  Cell Rep       Date:  2017-05-30       Impact factor: 9.423

2.  RORα binds to E2F1 to inhibit cell proliferation and regulate mammary gland branching morphogenesis.

Authors:  Gaofeng Xiong; Ren Xu
Journal:  Mol Cell Biol       Date:  2014-06-02       Impact factor: 4.272

3.  Characterization of Somatically-Eliminated Genes During Development of the Sea Lamprey (Petromyzon marinus).

Authors:  Stephanie A Bryant; Joseph R Herdy; Chris T Amemiya; Jeramiah J Smith
Journal:  Mol Biol Evol       Date:  2016-06-10       Impact factor: 16.240

4.  The association between MAD2 and prognosis in cancer: a systematic review and meta-analyses.

Authors:  Tara Byrne; Helen G Coleman; Janine A Cooper; W Glenn McCluggage; Amanda McCann; Fiona Furlong
Journal:  Oncotarget       Date:  2017-06-08

5.  p31comet-Induced Cell Death Is Mediated by Binding and Inactivation of Mad2.

Authors:  Hyun-Jin Shin; Eun-Ran Park; Sun-Hee Yun; Su-Hyeon Kim; Won-Hee Jung; Seon Rang Woo; Hyun-Yoo Joo; Su Hwa Jang; Hee Yong Chung; Sung Hee Hong; Myung-Haing Cho; Joong-Jean Park; Miyong Yun; Kee-Ho Lee
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.